Patents by Inventor Peter Andrew

Peter Andrew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10953078
    Abstract: The disclosure provides molecules with an affinity for (or an ability to bind to), sialic acid, for use in compositions, medicaments and methods for the treatment of sepsis, its symptoms and sepsis associated pathologies and immune responses.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: March 23, 2021
    Assignee: Pneumagen Limited
    Inventors: Helen Connaris, Garry Taylor, Hasan Yesilkaya, Peter Andrew
  • Publication number: 20190231853
    Abstract: The disclosure provides molecules with an affinity for (or an ability to bind to), sialic acid, for use in compositions, medicaments and methods for the treatment of sepsis, its symptoms and sepsis associated pathologies and immune responses.
    Type: Application
    Filed: September 20, 2017
    Publication date: August 1, 2019
    Inventors: Helen Connaris, Garry Taylor, Hasan Yesilkaya, Peter Andrew
  • Publication number: 20150313986
    Abstract: The invention relates to a novel method for producing bacterial or viral saccharides, such as capsular, immunogenic or membrane saccharides, in a plant cell. Also provided plants, plant cells, plant parts, and plant products comprising such a bacterial or viral saccharide. The invention is based upon the novel finding that bacterial enzymes can be used in a plant cell to produce bacterial or viral capsular, immunogenic and/or membrane saccharides.
    Type: Application
    Filed: December 10, 2013
    Publication date: November 5, 2015
    Applicants: THE UNIVERSITY OF LEICESTER, THE UNIVERSITY OF MANCHESTER
    Inventors: Ian Roberts, Peter Andrew, Garry Whitelam (deceased)
  • Publication number: 20090159918
    Abstract: A submount for a semiconductor light emitting device includes a semiconductor substrate having a cavity therein configured to receive the light emitting device. A first bond pad is positioned in the cavity to couple to a first node of a light emitting device received in the cavity. A second bond pad is positioned in the cavity to couple to a second node of a light emitting device positioned therein. Light emitting devices including a solid wavelength conversion member and methods for forming the same are also provided.
    Type: Application
    Filed: March 4, 2009
    Publication date: June 25, 2009
    Inventors: Bernd Keller, James Ibbetson, Peter Andrew, Gerald H. Negley
  • Publication number: 20060009463
    Abstract: The present invention relates to novel N-(3-rifamycinyl)-derivatives, namely N-(3-rifamycinyl)-carbamates, methods of their preparation and their use for the production of pharmaceutical preparations. The invention also concerns a composition and a method for treating or preventing mycobacterial infections, especially tuberculosis.
    Type: Application
    Filed: April 10, 2003
    Publication date: January 12, 2006
    Inventors: Dimcho Dimov, Nely Angelova, Asenov Grozdanov, Pavel Penev, Svetlana Haladgova, Desislava Mincheva, Stevka Paraskevova, Sashko Dekin, Iskra Atanasova, Gerrit Schuurmann, Ralph Kuhne, Peter Andrew, Jamilia Shafi, Jason Sharpe
  • Patent number: D329788
    Type: Grant
    Filed: May 23, 1990
    Date of Patent: September 29, 1992
    Inventor: Peter Andrew